[Study of thrombin generation in healthy children]

Laurie Talon1, Anne-Françoise Sapin1, Virginie Fourneyron1

  • 1Service d'hématologie biologique, Hôpital Estaing, Centre hospitalier universitaire de Clermont-Ferrand, France.

Insights

Pediatric coagulation is complex. Thrombin generation assays reveal that while children have lower procoagulant factors, their overall blood clotting balance is maintained, comparable to adults when thrombomodulin is present.

Area of Science:

  • Pediatric Hematology
  • Hemostasis and Thrombosis Research
  • Clinical Coagulation Studies

Background:

  • Pediatric coagulation assessment is challenging due to developmental differences in procoagulant and anticoagulant factors.
  • Conventional coagulation tests may not fully capture the hemostatic balance in children.

Purpose of the Study:

  • To evaluate the utility of the thrombin generation assay (TGA) in assessing coagulation in a pediatric population.
  • To compare TGA parameters in children with those in adults.

Main Methods:

  • Calibrated Automated Thrombography (CAT) was used to perform TGA in 586 pediatric subjects and 166 adults.
  • Assays were conducted using two tissue factor concentrations (1 pM and 5 pM), with and without thrombomodulin (TM).
  • Endogenous Thrombin Potential (ETP) was analyzed as a key indicator of thrombin generation.

Main Results:

  • In the absence of TM, pediatric subjects showed significantly lower ETP, consistent with reduced procoagulant factor levels.
  • In the presence of TM, ETP values in pediatric subjects fell within the adult reference range.
  • These findings suggest a maintained coagulation balance in the pediatric population.

Conclusions:

  • The thrombin generation assay is a valuable tool for evaluating coagulation in pediatric patients.
  • Despite lower factor levels, the pediatric hemostatic system demonstrates a balanced coagulation profile, particularly when considering the role of thrombomodulin.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.8K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
133
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.9K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
137
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.6K